Related Experiment Video

Updated: Apr 19, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

[Anti-angiogenic strategy: therapy optimization of non-squamous non-small cell lung carcinoma]

N Reinmuth1, M Reck1, C Grohé2

  • 1LungenClinic, Onkologischer Schwerpunkt, Großhansdorf; Mitglied des Deutschen Zentrums für Lungenforschung (DZL).

Pneumologie (Stuttgart, Germany)
|December 10, 2014
PubMed

Insights

Anti-VEGF therapy is crucial for non-squamous non-small cell lung cancer (NSCLC), but its efficacy is limited in many patients. This review explores new anti-angiogenic strategies to improve survival outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Context:

  • Anti-angiogenic therapy targeting vascular endothelial growth factor (VEGF) is a cornerstone in treating non-squamous non-small cell lung cancer (NSCLC).
  • Current anti-VEGF treatments show limitations in overall survival benefits across unselected patient populations.
  • The absence of validated predictive biomarkers hinders patient selection for anti-VEGF therapies.

Purpose:

  • To review the fundamental mechanisms of tumor angiogenesis.
  • To discuss emerging anti-angiogenic therapeutic strategies for NSCLC.
  • To identify potential approaches for enhancing patient survival in NSCLC.

Summary:

  • This review examines the role of tumor angiogenesis in non-squamous non-small cell lung cancer (NSCLC).
  • It highlights the limitations of current anti-vascular endothelial growth factor (VEGF) treatments in improving overall survival for unselected patients.
  • The review also explores novel therapeutic options aimed at improving outcomes through enhanced anti-angiogenic approaches.

Impact:

  • Provides insights into the biological basis of anti-angiogenic therapy in NSCLC.
  • Highlights the need for predictive biomarkers to personalize treatment selection.
  • Suggests new therapeutic avenues that could improve overall survival for NSCLC patients.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.9K
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:21

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

110

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K